Late SV40 factor (LSF) is a CP2 family transcription factor involved in cell cycle regulation. In liver cancer, LSF is an oncogene, in part due to its role in upregulation of osteopontin leading to increase tumor size. As a result, LSF is a potential target for drug discovery. LSF binds the p65 subunit of the transcription factor NFkB and also the transcription factor ying yang 1 (YY1). In this thesis, I show that binding of both YY1 and p65 occurs at the ubiquitin-like domain of LSF in U2OS cell extracts. Interestingly, when phosphatase inhibitors are added during preparation of U2OS cell extracts, the binding of YY1 and p65 to LSF shifts from the ubiquitin-like domain of LSF to the DNA binding domain. The role of a yet unidentified docking protein may be responsible for this shift in binding. In an attempt to map the specific region of the LSF sequence that is involved in these interactions, I have developed a peptide identification assay which utilizes protease digestion, protein mediated peptide capture, and LC ESI-MS. Through the use of this assay, I'm confident that the sequence(s) involved in these LSF protein-protein interactions can be further defined.
Identifer | oai:union.ndltd.org:bu.edu/oai:open.bu.edu:2144/14244 |
Date | 22 January 2016 |
Creators | Church, William David |
Source Sets | Boston University |
Language | en_US |
Detected Language | English |
Type | Thesis/Dissertation |
Page generated in 0.0019 seconds